Changes in Hong Kong stocks | Aurora-B (06681) opened more than 3% higher and obtained the first medical device registration certificate for cognitive function assessment in the field of depression issued by the Beijing Drug Administration

The Zhitong Finance App learned that Brainstorm-B (06681) opened more than 3% higher. As of press release, it had risen 3.35% to HK$1.235, with a turnover of HK$5.083 million.

According to the news, Brain Action Aurora-B issued an announcement. The company received a Class II medical device registration certificate for cognitive function assessment software for patients with depression issued by the Beijing Drug Administration (Beijing Administration) on the evening of October 27, 2026. This product is an independent software for evaluating cognitive function in patients with depression. It evaluates and issues results around the four dimensions of memory, attention, executive function, and information processing speed, making it easy for clinicians to understand patients' cognitive status and providing safe and effective evidence for subsequent treatment. Clinical trials of this product began in September 2024 and completed in August 2025.

According to the announcement, this product is the first medical device registration certificate obtained by the Beijing Bureau. It is also the first medical device registration certificate for cognitive function assessment in the field of depression. It marks that the company has achieved a breakthrough in registration in the field of cognitive assessment of mental illness, occupied a leading position in the market, and further improved the company's digital medical product layout for cognitive impairment. The board of directors believes that the above registration results will help strengthen the Group's position in the digital medical field for cognitive impairment and conform to the overall interests of the Group and shareholders.